Michael A. Davies

The University of Texas MD Anderson Cancer Center

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.800Author DataRank

Indexed papers

12in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 12 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.03.186908

Top 34%

0.578DataRank

Top 34%10 citations

Jun Li, Mei‐Ju Chen, Zhenlin Ju, Nicole K. Nesser, Katie Johnson-Camacho +20 more

Papers

Driven by 97 papers — median percentile 0. Top paper: “Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study”.

Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study

The Lancet Oncology(2021)10.1016/s1470-2045(20)30726-9

N/A

4.9DataRank · unranked

94 citations

Jennifer Wiggins, Broderick C. Corless, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf +12 more

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell(2022)10.1016/j.ccell.2022.04.004

N/A

4.7DataRank · unranked

350 citations

Daniel H. Johnson, Noha Abdel‐Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher +32 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

3.5DataRank · unranked

197 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0870

N/A

1.6DataRank · unranked

53 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland +40 more

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

Pigment Cell & Melanoma Research(2020)10.1111/pcmr.12861

N/A

1.6DataRank · unranked

57 citations

Keiran S.M. Smalley, Priscilla K. Brastianos, Michael A. Davies, Ian E. McCutcheon, James K. Liu +13 more

Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study

The Oncologist(2021)10.1002/onco.13795

N/A

1.5DataRank · unranked

43 citations

Douglas B. Johnson, Ryan J. Sullivan, R. Amaria, Keith T. Flaherty, Jeffrey A. Sosman +2 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2719 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Cancer Discovery(2016)10.1158/2159-8290.cd-15-1545

N/A

1.0DataRank · unranked

1012 citations

Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto +39 more

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins

Molecular Cancer(2025)10.1186/s12943-024-02198-2

N/A

0.923DataRank · unranked

44 citations

Fatemeh Masrorpour, Hong Jiang, Iqbal Mahmud, Yue Lu, Ailing Huang +25 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Cancer(2021)10.1002/cncr.34004

N/A

0.890DataRank · unranked

21 citations

Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1228

N/A

0.849DataRank · unranked

287 citations

Eugenie Kim, Victoria Osorio-Vasquez, Sophia Doll, Sophia Bustraan, Roger J. Liang +35 more

Multi-modal molecular programs regulate melanoma cell state

Nature Communications(2022)10.1038/s41467-022-31510-1

N/A

0.812DataRank · unranked

26 citations

Junna Oba, Chang‐Jiun Wu, Haifeng Zhu, Tatiana V. Karpinets, Caitlin Creasy +31 more

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell(2022)10.1016/j.cell.2022.06.007

N/A

0.807DataRank · unranked

216 citations

Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz +54 more

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature Genetics(2021)10.1038/s41588-020-00750-6

N/A

0.790DataRank · unranked

193 citations

Jessica Giordano, Anuj Srivastava, Min Jin Ha, Michael W. Lloyd, Roebi de Bruijn +57 more

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

Nature Communications(2021)10.1038/s41467-020-20600-7

N/A

0.784DataRank · unranked

185 citations

Thomas Connelly, Robin Choi, Hyeree Choi, Anastasia Samarkina, Ling Li +52 more

Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

Molecular Cancer Therapeutics(2009)10.1158/1535-7163.mct-09-0459

N/A

0.777DataRank · unranked

177 citations

Jonathan C. Trent, Katherine Stemke-Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Nature Communications(2022)10.1038/s41467-022-29539-3

N/A

0.716DataRank · unranked

117 citations

Yanshuo Chu, Mercy Misoi, María E. Suarez‐Almazor, Jean Tayar, Huifang Lu +33 more

Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2581

N/A

0.636DataRank · unranked

17 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis

Acta Neuropathologica(2021)10.1007/s00401-020-02256-1

N/A

0.626DataRank · unranked

64 citations

Prit Benny Malgulwar, Grant M. Fischer, Xiaoding Hu, Xizeng Mao, Xingzhi Song +9 more

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.03.186908

Top 34%

0.578DataRank

Top 34%10 citations

Jun Li, Mei‐Ju Chen, Zhenlin Ju, Nicole K. Nesser, Katie Johnson-Camacho +20 more

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002449

N/A

0.574DataRank · unranked

45 citations

Rodabe N. Amaria, Amer Najjar, Laszlo Radvanyi, Cara Haymaker, Marie-Andrée Forget +18 more

iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation

Frontiers in Oncology(2021)10.3389/fonc.2021.631766

N/A

0.557DataRank · unranked

40 citations

Dai Ogata, Jason Roszik, Yong Qin, Sun‐Hee Kim, Michael T. Tetzlaff +5 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0.542DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016

N/A

0.538DataRank · unranked

35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more

Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-1016

N/A

0.524DataRank · unranked

32 citations

Timothy J. Purwin, Anna Han, Vivian Chua, Prem Patel, Usman Baqai +7 more

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

Frontiers in Immunology(2023)10.3389/fimmu.2023.1237715

N/A

0.500DataRank · unranked

27 citations

Xia Bu, Yunfei Wang, Michael R. Gomez, James A. Torchia, Ping Hua +7 more

Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases

Neuro-Oncology Advances(2021)10.1093/noajnl/vdaa177

N/A

0.500DataRank · unranked

27 citations

Renato Guerrieri, Qianghua Hu, Aron Y. Joon, Swaminathan Kumar, Lauren E. Haydu +9 more

High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens

Scientific Reports(2021)10.1038/s41598-021-88391-5

N/A

0.500DataRank · unranked

27 citations

Lauren E. Haydu, Ping Song, Jianyi Nie, Michael T. Tetzlaff, Lawrence N. Kwong +4 more

Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy

Nature Communications(2024)10.1038/s41467-024-50881-1

N/A

0.478DataRank · unranked

8 citations

Junhua Wang, Emily Wilson, Coulson P. Rich, Aaron Rogers, Zongzhong Tong +14 more

Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0471

N/A

0.464DataRank · unranked

21 citations

Michael W. Lloyd, Soner Koc, Yvonne A. Evrard, Lisa M. McShane, Michael T. Lewis +29 more

Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer

JCO Precision Oncology(2023)10.1200/po.22.00490

N/A

0.449DataRank · unranked

19 citations

Weilu Zhao, Shorook Na’ara, Frederico O. Gleber‐Netto, Tongxin Xie, Shahrukh R. Ali +12 more

A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies

Nature Cancer(2024)10.1038/s43018-024-00817-x

N/A

0.449DataRank · unranked

19 citations

Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju +9 more

Microbial signals in primary and metastatic brain tumors

Nature Medicine(2025)10.1038/s41591-025-03957-4

N/A

0.449DataRank · unranked

19 citations

Ashish Damania, Brenda Melendez, Bharat Singh, Fabiana J. Veguilla, Rebecca Soto +61 more

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-1060

N/A

0.434DataRank · unranked

17 citations

Yuzhong Jeff Meng, Marie‐Andrée Forget, Tatiana V. Karpinets, Katarzyna Tomczak, Chip Stewart +22 more

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13059

N/A

0.425DataRank · unranked

16 citations

Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire +22 more

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Cancer Medicine(2020)10.1002/cam4.3474

N/A

0.425DataRank · unranked

16 citations

Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang +13 more

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology(2023)10.1016/j.annonc.2023.06.007

N/A

0.396DataRank · unranked

13 citations

Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton +28 more

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Cancers(2021)10.3390/cancers13215301

N/A

0.385DataRank · unranked

12 citations

Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han +18 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0.385DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more

Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma

British Journal of Cancer(2024)10.1038/s41416-024-02866-6

N/A

0.385DataRank · unranked

12 citations

Jason Roszik, Rajat Bhattacharya, Md Alauddin, Iqbal Mahmud, Sirisha Yadugiri +12 more

Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade

Research Square(2023)10.21203/rs.3.rs-3161761/v1

N/A

0.360DataRank · unranked

10 citations

Erez N. Baruch, Priyadahrshini Nagarajan, Frederico O. Gleber‐Netto, Xiayu Rao, Tongxin Xie +34 more

Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic (met) uveal melanoma (UM) tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9513

N/A

0.350DataRank · unranked

6 citations

Marie‐Andrée Forget, Firas Kreidieh, Meredith Pelster, Michael A. Davies, Rodabe N. Amaria +3 more

Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.01.034

N/A

0.346DataRank · unranked

4 citations

Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani +12 more

Neoadjuvant-adjuvant pembrolizumab in clinical stage IIB/C melanoma.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.9502

N/A

0.345DataRank · unranked

9 citations

Mohammad Saad Farooq, Phyllis A. Gimotty, Tara C. Mitchell, Ravi K. Amaravadi, Lynn M. Schuchter +11 more

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

OncoImmunology(2025)10.1080/2162402x.2025.2546402

N/A

0.323DataRank · unranked

7 citations

Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab +15 more

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506051

N/A

0.300DataRank · unranked

4 citations

Alvin Shi, Ming Tang, Marcus Ho, Christopher Terranova, Kyriaki Galani +36 more

Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors

NAR Cancer(2022)10.1093/narcan/zcac038

N/A

0.269DataRank · unranked

5 citations

Shaoheng Liang, Chunyu Xu, Yanjun Wei, Yunfei Wang, Yukun Tan +12 more

Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524923

N/A

0.269DataRank · unranked

5 citations

Min Xiao, Andrew V. Kossenkov, Tetiana Godok, Gregory Schuyler Brown, Dylan Fingerman +13 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9523

N/A

0.259DataRank · unranked

4 citations

Christopher P. Vellano, Miles C. Andrews, Russell G. Witt, Manoj Chelvanambi, Jennifer L. McQuade +15 more

Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9511

N/A

0.239DataRank · unranked

3 citations

Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349

Top 62%

0.222DataRank

Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Loss of HD-PTP function results in lipodystrophy, defective cellular signaling and altered lipid homeostasis

Journal of Cell Science(2024)10.1242/jcs.262032

N/A

0.191DataRank · unranked

2 citations

Brian A. Davies, Johanna A. Payne, Cole P Martin, Annabel Y. Minard, Bennett G. Childs +17 more

Safety and preliminary efficacy of intrathecal (IT) and intravenous (IV) nivolumab (N) for patients (pts) with leptomeningeal disease (LMD).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9554

N/A

0.174DataRank · unranked

2 citations

Ida John, Suzanne Phillips, Lauren See, Roland L. Bassett, Ruitao Lin +15 more

Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases

Journal of Investigative Dermatology(2024)10.1016/j.jid.2024.09.005

N/A

0.165DataRank · unranked

2 citations

Alcida Karz, Marta R. Hidalgo, Borja Gómez-Cabañes, Adolfo López, José F. Català-Senent +10 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Melanoma Brain Metastasis

Hematology/Oncology Clinics of North America(2024)10.1016/j.hoc.2024.05.008

N/A

0.165DataRank · unranked

2 citations

Yusuf Açıkgöz, Michael A. Davies, Merve Hasanov

Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

Acta Neuropathologica Communications(2025)10.1186/s40478-025-01978-1

N/A

0.117DataRank · unranked

1 citations

Meredith S. Pelster, Merve Hasanov, Renato Guerrieri, Courtney W. Hudgens, Debora Alejandra Ledesma +19 more

Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2015

N/A

0.113DataRank · unranked

1 citations

Yitao Yang, Sheila Duncan, Sherise D. Ferguson, Jennifer A. Wargo, Elizabeth M. Burton +5 more

Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier

Nutrients(2025)10.3390/nu18010040

N/A

0.104DataRank · unranked

1 citations

Satabdi Saha, Nazli Dizman, Michelle Rohlfs, Elizabeth Sirmans, J. M. Gardner +17 more

Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.12.575058

N/A

0.104DataRank · unranked

1 citations

Jason Roszik, Rajat Bhattacharya, Md Alauddin, Iqbal Mahmud, Sirisha Yadugiri +11 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965.v1

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

(2023)10.1158/1078-0432.c.6533110

Top 100%

0DataRank

Top 100%0 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608.v1

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

(2023)10.1158/1078-0432.c.6533110.v1

Top 100%

0DataRank

Top 100%0 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

Data from Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo

(2023)10.1158/1535-7163.c.6539317

N/A

0DataRank · unranked

0 citations

Curtis H. Kugel, Michael J. Vido, Adam C. Berger, Timothy J. Purwin, Allison Goldberg +6 more

Data from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

(2023)10.1158/2326-6066.c.6550279.v1

N/A

0DataRank · unranked

0 citations

Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley +15 more

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.25.456956

N/A

0DataRank · unranked

0 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matthew Lastrapes, Matthew R. Strickland +39 more

Targeted therapy strategies for melanoma brain metastasis

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab131

N/A

0DataRank · unranked

12 citations

Paul W. Sperduto, Michael A. Davies, Chantal Saberian

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0905

N/A

0DataRank · unranked

48 citations

Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley +15 more

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08

Top 100%

0DataRank

Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress

Science Signaling(2024)10.1126/scisignal.adn8376

N/A

0DataRank · unranked

6 citations

Melisa Lopez-Anton, Mizue Terai, Ryota Tanaka, Usman Baqai, Timothy J. Purwin +13 more

Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0024

N/A

0DataRank · unranked

3 citations

Dennis A. Agardy, Swaminathan Kumar, Alexandros Kourtesakis, Tamara Boschert, Kristine Jähne +7 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma

British Journal of Cancer(2020)10.1038/s41416-019-0724-y

N/A

0DataRank · unranked

27 citations

Claudia Capparelli, Dan A. Erkes, Timothy J. Purwin, Shea A. Heilman, Adam C. Berger +3 more

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma

Cell Death and Disease(2020)10.1038/s41419-020-03097-2

N/A

0DataRank · unranked

19 citations

Huiqin Chen, Gianluca Maddalo, Rainer Tuominen, Vito W. Rebecca, Meenhard Herlyn +4 more

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition

Journal of Investigative Dermatology(2020)10.1016/j.jid.2020.02.047

N/A

0DataRank · unranked

43 citations

Jessica L.F. Teh, Timothy J. Purwin, Inna Chervoneva, Michael A. Davies, Katherine L. Nathanson +5 more

FOXD3 Regulates VISTA Expression in Melanoma

Cell Reports(2020)10.1016/j.celrep.2019.12.036

N/A

0DataRank · unranked

85 citations

Meghan Knecht, Mehri Mollaee, Zhijiu Zhong, Dan A. Erkes, Peter A. McCue +9 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745

Top 100%

0DataRank

Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000289

N/A

0DataRank · unranked

97 citations

Hampartsoum B. Barsoumian, Grant M. Fischer, Liangpeng Yang, Vivek Verma, Ahmed Younes +9 more

Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps12147

N/A

0DataRank · unranked

0 citations

Teresa Kuś, Salah-Eddine Bentebibel, Jennifer L. McQuade, Isabella Claudia Glitza, Rodabe N. Amaria +11 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120

N/A

0DataRank · unranked

1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

iScience(2023)10.1016/j.isci.2023.106791

N/A

0DataRank · unranked

10 citations

Da Teng, Evelyn de Groot, Man Li, Sebastian Trousil, Che‐Hung Shen +5 more

Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care

Pigment Cell & Melanoma Research(2023)10.1111/pcmr.13116

N/A

0DataRank · unranked

8 citations

Adrienne Boire, Priscilla K. Brastianos, Harriet M. Kluger, Eva Hernando‐Monge, Peter Forsyth +6 more

Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105418

N/A

0DataRank · unranked

7 citations

Alison Kurimchak, Isabella V. Trachtenberg, Timothy J. Purwin, Jelan I. Haj, Anna Han +10 more

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth

Cancers(2023)10.3390/cancers15133451

N/A

0DataRank · unranked

10 citations

Dzmitry Mukha, Vivian Chua, Timothy J. Purwin, Manoela Tiago, Bhavik Modasia +15 more

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

Neuro-Oncology(2022)10.1093/neuonc/noac251

N/A

0DataRank · unranked

22 citations

Denái R. Milton, Alicia Bea Davies, Elizabeth Sirmans, Chantal Saberian, Eliza Posada +22 more

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade

Journal of Clinical Investigation(2022)10.1172/jci154152

N/A

0DataRank · unranked

44 citations

Joost Koetsier, Trevin Kurtanich, Michael Engelbrecht Nielsen, Glenn Winn, Yunfei Wang +25 more

Data from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

(2023)10.1158/0008-5472.c.6497325

Top 100%

0DataRank

Top 100%0 citations

Ana M. González-Angulo, Aňa Lluch, Richard M. Neve, Wen-lin Kuo, Michael A. Davies +17 more

Merged pdf from ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma

(2023)10.1158/0008-5472.22419945

Top 100%

0DataRank

Top 100%0 citations

Timothy J. Purwin, Shea A. Heilman, Inna Chervoneva, Peter A. McCue, Adam C. Berger +5 more

Merged pdf from ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22419945.v1

Top 100%

0DataRank

Top 100%0 citations

Timothy J. Purwin, Shea A. Heilman, Inna Chervoneva, Peter A. McCue, Adam C. Berger +5 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Michael A. Davies

Indexed papers

Top data-sharing exemplar

Papers